SCHEMBL21110282

SCHEMBL21110282

CCCCCC(C)(CCCCC)c1nsc(C)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22420080 0.98 SMN1; SMN2 (0.32)
SCHEMBL20987843 0.98 SMN1; SMN2 (0.32)
SCHEMBL21720486 0.97 SMN1; SMN2 (0.31)
SCHEMBL18867100 0.92 SMN1; SMN2 (0.30)
SCHEMBL18948710 0.84 CNR2 (0.36)
SCHEMBL23454203 0.81 SMN1; SMN2 (0.32)
SCHEMBL22545662 0.81 SMN1; SMN2 (0.32)
SCHEMBL22545678 0.81 SMN1; SMN2 (0.32)
SCHEMBL25913921 0.81 SMN1; SMN2 (0.32)
SCHEMBL19363808 0.80

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10596172-B2 2,4-disubstituted pyrimidines useful as kinase inhibitors CELGENE CAR LLC (BM) 2020-03-24 US disclosed
US-20190192512-A1 HETEROARYL COMPOUNDS AND USES THEREOF BRISTOL-MYERS SQUIBB COMPANY 2019-06-27 US disclosed